Sleep Disorders Trial, Recruiting NCT07062770 Sponsor: Brigham and Women's Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07062770
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with moderate to severe sleep apnea (stopping breathing 20 or more times per hour during sleep)
  • You currently use a CPAP machine or have used one in the past
  • Your CPAP pressure setting is no higher than 13 cmH2O, if you know this information (confirm with trial site if unsure)
  • You are between 21 and 70 years old
  • Your body mass index (a measure of weight relative to height) is between 18 and 40

Who may not be able to join:

  • You breathe mainly through your mouth while sleeping, based on your own experience
  • You need extra oxygen or any other breathing support during the night
  • You have a serious heart or lung condition
  • You have any medical condition that is currently unstable or is in an active, changing phase
  • You have any other sleep disorder besides sleep apnea, including insomnia

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Atqiya Aishah, PhD, Harvard Medical School & Brigham and Women's Hospital

Phone: 857 396 3808

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
27 May 2025
Est. completion
1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in flow-adjusted average inspired oxygen fraction (FiO₂) during wake.; Change in flow-adjusted average inspired oxygen fraction (FiO₂) during sleep.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov